PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Engineering, Rowan University, Glassboro, NJ, USA.\', \'Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.\', \'The Center for Substance Abuse Research Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 19140, USA.\', \'The Shriners Hospitals Pediatric Research Center, Philadelphia, PA, 19140, USA.\', \'Department of Biomedical Engineering, Rowan University, Glassboro, NJ, USA. galie@rowan.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11481-021-10029-0
?:hasPublicationType
?:journal
  • Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34687399
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34687399>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34687399>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all